Ixazomib enhances the antitumor effect of brigatinib in TP53-mutated EML4-ALK lung cancer cells

International Journal of Lung Cancer · Elsevier

Аннотация

Publication date: September 2026 Source: International Journal of Lung Cancer, Volume 1, Issue 3 Author(s): Sachiko Arai, Azusa Tanimoto, Koji Fukuda, Shigeki Nanjo, Shigeki Sato, Hiroshi Kotani, Seiji Yano

Читать у издателя →

Похожие статьи